Longevity Health Holdings plans to merge with True Health, which operates plasma collection company THPlasma, in an all-stock transaction. The longevity and healthy aging company said Monday the ...

The evidence is clear: if everyone in the world had access to a basic health check once a year, we could increase life ...

Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging ("Longevity", the "Company", "we", "our", or "us") ...

Dr. Kennedy is a globally recognized leader in aging biology and translational longevity research. Dr. Kennedy is currently a ...

Longevity Health Holdings to remain listed on Nasdaq South Side biotech company announces merger plans South Side biotech ...

Additional order drives cumulative demand to over $20 million in fiscal 2025 from this global leading customer ...

Under the terms of the agreement, THPlasma is valued at $59 million plus a $20 million earnout tied to financial performance. The valuation represents 2.5 times THPlasma’s estimated FY26 revenue ...

Circulate Health, a Seattle health longevity startup, today announced $12 million in seed funding to expand its plasma ...

Shares of Longevity Health Holdings Inc. (NASDAQ:XAGE) soared 155% on Tuesday after the company announced a definitive ...

Loyal has a trio of longevity drugs in the works, including two meant to specifically target larger breeds that typically ...

The quest for longevity has captivated humanity since the dawn of civilization—from ancient Egyptian mummification rituals and Ponce de León's search for the fountain of youth to Renaissance polymaths ...

The global biotechnology market stands poised to reach an unprecedented $5.85 trillion by 2034. The compound annual growth of ...